Cargando…
Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model
BACKGROUND: Patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD), like those with idiopathic pulmonary fibrosis (IPF), might develop an unexpected acute exacerbation (AE)—a rapidly progressing and deadly respiratory decline. Although AE incidence and risk factors in RA-IL...
Autores principales: | Hozumi, Hironao, Kono, Masato, Hasegawa, Hirotsugu, Kato, Shinpei, Inoue, Yusuke, Suzuki, Yuzo, Karayama, Masato, Furuhashi, Kazuki, Enomoto, Noriyuki, Fujisawa, Tomoyuki, Inui, Naoki, Nakamura, Yutaro, Yokomura, Koshi, Nakamura, Hidenori, Suda, Takafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915517/ https://www.ncbi.nlm.nih.gov/pubmed/35277175 http://dx.doi.org/10.1186/s12931-022-01978-y |
Ejemplares similares
-
Pulse oximetric saturation to fraction of inspired oxygen (SpO(2)/FIO(2)) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease
por: Koyauchi, Takafumi, et al.
Publicado: (2020) -
Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study
por: Suzuki, Takahito, et al.
Publicado: (2021) -
Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study
por: Koyauchi, Takafumi, et al.
Publicado: (2022) -
Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis
por: Suzuki, Yuzo, et al.
Publicado: (2021) -
Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study
por: Suzuki, Yuzo, et al.
Publicado: (2021)